Clinical Trial Results

Patisiran-Lipid Nanoparticle (LNP) Pregnancy Surveillance Program

A Study Comparing JNJ-79635322 and Teclistamab in Participants With Relapsed or Refractory Multiple Myeloma

Testing the Effectiveness of a Combination Targeted Therapy (ViPOR) for Patients With Relapsed and/or Refractory Aggressive B-cell Lymphoma

Frontline T-cell Engager vs Autologous Stem Cell Transplant (ASCT) and Measurable Residual Disease (MRD)-Guided Sequential Intensification thERapy in Multiple Myeloma

Thrombectomy Using Pulsed Aspiration for Reperfusion of Brain Occlusions

Specimen Collection From Pregnant Women at Increased Risk for Fetal Aneuploidy

Early Angiotensin II in the Emergency Department

COVID-19 Coagulopathy Extension Study

Soquelitinib vs Standard of Care in Participants With Relapsed/Refractory Peripheral T-cell Lymphoma Not Otherwise Specified, Follicular Helper T-cell Lymphomas, or Systemic Anaplastic Large-cell Lymphoma